Tempest Therapeutics Inc (NASDAQ:TPST)
| 1.35 Delayed Data As of Jun 08 |  -0.04 / -2.88%Today’s Change | 1.06 Today|||52-Week Range 4.21 | +17.39% Year-to-Date |
Latest TPST News | Press Releases
No recent news for Tempest Therapeutics Inc.
Today’s Trading
| Previous close | 1.39 |
| Today’s open | 1.37 |
| Day’s range | 1.35 - 1.37 |
| Volume | 676 |
| Average volume (3 months) | 183,697 |
| Market cap | $16.8M |
Data as of 3:59pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | +58.59% |
| Earnings growth (this year) | +29.13% |
| Earnings growth (next 5 years) | +22.80% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.84 |
Competitors
Data as of 2:02pm ET, 06/08/2023
Financials
| Next reporting date | August 14, 2023 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$35.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Brisbane, California |
Forecasts
